These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 21677777)
1. Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease. Xiong N; Xiong J; Khare G; Chen C; Huang J; Zhao Y; Zhang Z; Qiao X; Feng Y; Reesaul H; Zhang Y; Sun S; Lin Z; Wang T PLoS One; 2011; 6(6):e20677. PubMed ID: 21677777 [TBL] [Abstract][Full Text] [Related]
2. Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression. Bandookwala M; Sahu AK; Thakkar D; Sharma M; Khairnar A; Sengupta P Neurosci Lett; 2019 Oct; 711():134438. PubMed ID: 31422100 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. Yuan WJ; Yasuhara T; Shingo T; Muraoka K; Agari T; Kameda M; Uozumi T; Tajiri N; Morimoto T; Jing M; Baba T; Wang F; Leung H; Matsui T; Miyoshi Y; Date I BMC Neurosci; 2008 Aug; 9():75. PubMed ID: 18671880 [TBL] [Abstract][Full Text] [Related]
4. Edaravone prevents neurotoxicity of mutant L166P DJ-1 in Parkinson's disease. Li B; Yu D; Xu Z J Mol Neurosci; 2013 Oct; 51(2):539-49. PubMed ID: 23657982 [TBL] [Abstract][Full Text] [Related]
5. [The study of the protective effect and its mechanism of Edaravone to neurons with hydrogen peroxide stimulated]. Long H; Zhang N; Fan J; Li QQ; Li YM; Tang J; Cheng G; Yin GY; Cai WH Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):266-71. PubMed ID: 23859332 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent]. Tanaka M Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142 [TBL] [Abstract][Full Text] [Related]
7. Improvement of postischemic dopaminergic dysfunction by edaravone, a free radical scavenger. Akiyama Y; Miwa S J Pharmacol Sci; 2007 May; 104(1):99-102. PubMed ID: 17452805 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells. Watabe M; Nakaki T Mol Pharmacol; 2008 Oct; 74(4):933-40. PubMed ID: 18599602 [TBL] [Abstract][Full Text] [Related]
9. [Research and development of the free radical scavenger edaravone as a neuroprotectant]. Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127 [TBL] [Abstract][Full Text] [Related]
10. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391 [TBL] [Abstract][Full Text] [Related]
12. Edaravone protects cortical neurons from apoptosis by inhibiting the translocation of BAX and Increasing the interaction between 14-3-3 and p-BAD. Fan J; Zhang N; Yin G; Zhang Z; Cheng G; Qian W; Long H; Cai W Int J Neurosci; 2012 Nov; 122(11):665-74. PubMed ID: 22757651 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Abdin AA; Hamouda HE Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789 [TBL] [Abstract][Full Text] [Related]
14. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents. Garabadu D; Agrawal N Neuromolecular Med; 2020 Jun; 22(2):314-330. PubMed ID: 31916219 [TBL] [Abstract][Full Text] [Related]
15. Dopamine, a key factor of mitochondrial damage and neuronal toxicity on rotenone exposure and also parkinsonic motor dysfunction-Impact of asiaticoside with a probable vesicular involvement. Margabandhu G; Vanisree AJ J Chem Neuroanat; 2020 Jul; 106():101788. PubMed ID: 32278634 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats. Zhou S; Yu G; Chi L; Zhu J; Zhang W; Zhang Y; Zhang L Neurotoxicology; 2013 Sep; 38():136-45. PubMed ID: 23932983 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease. Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291 [TBL] [Abstract][Full Text] [Related]
18. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991 [TBL] [Abstract][Full Text] [Related]
19. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Higashi Y; Jitsuiki D; Chayama K; Yoshizumi M Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):85-93. PubMed ID: 18221078 [TBL] [Abstract][Full Text] [Related]
20. The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury. Itoh T; Satou T; Nishida S; Tsubaki M; Hashimoto S; Ito H Neurotox Res; 2009 Nov; 16(4):378-89. PubMed ID: 19590930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]